Drug intelligence / Profile preview

SilvaSorb

Development stage
Unknown
Lead developer
AcryMed
Modality
Hydrogel Systems → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

SilvaSorb is a silver-based antimicrobial wound care product available in several formats, including gels, sheets, and non-adherent dressings. Developed by AcryMed (later acquired by Medline Industries), it utilizes a proprietary polyacrylate hydrogel technology to provide the controlled and sustained release of ionic silver to the wound bed for up to several days. It is primarily indicated for the management of various wound types, such as partial-thickness burns, pressure ulcers, diabetic foot ulcers, and surgical incisions. The product is designed to maintain a moist wound-healing environment while providing a broad-spectrum antimicrobial barrier against pathogens, including antibiotic-resistant strains like MRSA and VRE. Its efficacy is derived from the biocidal activity of silver ions, which disrupt bacterial cell membranes and essential metabolic processes.

Brand names
SilvaSorbSilvaSorb Gel
Other names
Silver nanoparticle gelSilver-containing antimicrobial gelSilvaSorb Dressing
02

Targets

Neuraminidase

Beyond the preview

Go deeper on SilvaSorb.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SilvaSorb.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call